NVO
Novo Nordisk A/S
$49.46
-$0.58(-1.16%)
52
Overall
60
Value
36
Tech
60
Quality
Market Cap
$232.40B
Volume
20.02M
52W Range
$45.05 - $112.52
Target Price
$60.14
EPS Estimates Overview
| Current Quarter | $0.75 | Next Quarter | $0.95 |
| Current Year | $3.66 | Next Year | $3.91 |
| QoQ Growth | +26.7% | YoY Growth | +6.8% |
| 3Y EPS CAGR | +29.7% | Target Price | $60.14 |
| Consensus | Buy | Upside | +21.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVO | $49.46 | -1.2% | 20.02M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |